Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.

Genetic analysis of hypertrophic cardiomyopathy (HCM), a mendelian form of cardiac hypertrophy, indicates that the primary defect is in sarcomeric function. However, the initial proposal that depressed myocardial contraction leads to a 'compensatory' hypertrophy has proven inconsistent wit...

Detaylı Bibliyografya
Asıl Yazarlar:	Ashrafian, H, Redwood, C, Blair, E, Watkins, H
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2003

Benzer Materyaller

Myocardial dysfunction in hypertrophic cardiomyopathy.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

The genetics of hypertrophic cardiomyopathy: Teare redux.
Yazar:: Watkins, H, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Functional analysis of hypertrophic cardiomyopathy missense mutations in the light meromyosin region of beta myosin heavy chain
Yazar:: Redwood, C, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Inherited cardiomyopathies.
Yazar:: Watkins, H, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Inherited cardiomyopathies.
Yazar:: Watkins, H, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Mutations in the gamma2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Exercise-induced ventricular dysfunction in hypertrophic cardiomyopathy: stunning by any other name?
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Hypertrophic cardiomyopathy mutations in the gamma 2 subunit of AMP-activated kinase suggest a central role of energy compromise in disease pathogenesis
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy.
Yazar:: Elliott, K, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Linked genetic modifiers in hypertrophic cardiomyopathy
Yazar:: Ektisham, J, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Investigation of troponin I mutations causing familial hypertrophic cardiomyopathy
Yazar:: Abdulrazzak, H, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
Yazar:: Kramer, CM, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Effects of hypertrophic cardiomyopathy mutations in troponin I on contractility of skinned cardiac muscle fibres
Yazar:: Burton, D, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
Yazar:: Carballo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Sudden death in hypertrophic cardiomyopathy.
Yazar:: Watkins, H
Baskı/Yayın Bilgisi: (2000)

Altered inhibitory and troponin C-binding activities in cardiac troponin I mutants known to cause hypertrophic cardiomyopathy
Yazar:: Elliott, K, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
Yazar:: Carballo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Delineating the role of adenosine monophosphate (AMP)-activated protein kinase (AMP) gamma 2 subunit in hypertrophic cardiomyopathy (HCM)
Yazar:: Grignani, R, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
Yazar:: Robinson, P, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
Yazar:: Ariga, R, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Novel mutations in cardiac MYBPC3 causing early onset malignant hypertrophic cardiomyopathy
Yazar:: Carballo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
Yazar:: Ariga, R, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Is DNA testing for hypertrophic cardiomyopathy cost-effective?
Yazar:: Wordsworth, S, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Double mutations in CIS can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
Yazar:: Blair, E, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
Yazar:: Carballo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
Yazar:: Raman, B, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.
Yazar:: Karamitsos, T, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

METABOLIC ALTERATION IN HYPERTROPHIC CARDIOMYOPATHY (METAL-HCM STUDY): RANDOMISED DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF PERHEXILINE THERAPY IN PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
Yazar:: Abozguia, K, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments.
Yazar:: Robinson, P, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Impaired left ventricular energy metabolism in hypertrophic cardiomyopathy is not due to fibrosis.
Yazar:: Petersen, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

HYPERTROPHIC CARDIOMYOPATHY AND MYOCARDIAL CRYPT OF THE LEFT VENTRICLE
Yazar:: Yu. V. Frolova, ve diğerleri
Baskı/Yayın Bilgisi: (2017-02-01)

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance
Yazar:: Carballo, S, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.
Yazar:: Ashrafian, H, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

DEVELOPMENT AND CHARACTERISATION OF A NOVEL KNOCK-IN MODEL OF PRKAG2 CARDIOMYOPATHY
Yazar:: Yavari, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)